Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion type Assertion NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_head.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion description "[The frequency of the HLA-Bw4 specificity, which is the ligand for the inhibitory KIR3DL1, was significantly reduced in MS patients as compared with controls (41.4% vs 55.1%, p(uncorrected (uc)) = 4.6 x 10(-6)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_provenance.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion evidence source_evidence_literature NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_provenance.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion SIO_000772 19630074 NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_provenance.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion wasDerivedFrom gad-20150221 NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_provenance.
- NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_assertion wasGeneratedBy ECO_0000203 NP96529.RAGlzHNFT22WksZDGFRN209UHZl7ueRdQeKUoH94qw1Yg130_provenance.